Tag Archive for: Aldena Therapeutics

Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology

Boston, Massachusetts, April 26, 2023 – Aldena Therapeutics Inc. (Aldena), a private biotech company pioneering siRNA-based therapies for dermatological indications, and Empa, the Swiss Federal research institute for materials science and technology, have been awarded a joint 600’000 CHF grant by InnoSuisse, the Swiss Innovation Agency. This StarCURE grant seeks to co-develop microneedle particles as […]

Aldena Therapeutics Accelerates its Novel and Disruptive Approach to Immuno-Dermatology

Founded by Medicxi with Georgia Tech and UMass scientists, supported by US $30M investment from Medicxi Developing advanced, long-lasting therapies for dermatological diseases through radical new transepidermal delivery of proprietary siRNAs Led by dermatology veteran Thibaud Portal as CEO with a Scientific Advisory Board chaired by Nobel Prize Laureate, Craig Mello Boston, Massachusetts, March 16th, […]